Reports for PHARMASCIENCE INC
Company Name
PHARMASCIENCE INC
Totals |
||
Shortage reports |
1319 |
|
| Actual shortage: | 60 (5%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 36 (3%) | |
| Resolved: | 1223 (93%) | |
Discontinuation Reports |
287 |
|
| To be discontinued: | 2 (1%) | |
| Discontinued: | 283 (99%) | |
| Reversed: | 2 (1%) | |
Late reports |
210 (13%) |
|
Overdue reports |
27 (44%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMS-QUETIAPINE | 300MG | TABLET | Resolved | 2017-10-12 | 2017-10-28 | 25801 |
| PMS-QUINAPRIL | 5MG | TABLET | Resolved | 2017-07-25 | 2019-11-15 | 17075 |
| PMS-QUINAPRIL | 10MG | TABLET | Resolved | 2017-09-08 | 2019-11-15 | 21709 |
| PMS-QUINAPRIL | 20MG | TABLET | Resolved | 2017-10-12 | 2019-10-30 | 25804 |
| PMS-QUINAPRIL | 40MG | TABLET | Actual shortage | 2024-09-12 | 2025-04-25 | 237391 |
| PMS-QUINAPRIL | 20MG | TABLET | Actual shortage | 2025-05-12 | 2025-05-12 | 257028 |
| PMS-QUINAPRIL | 10MG | TABLET | Resolved | 2022-09-27 | 2023-05-17 | 170269 |
| PMS-QUINAPRIL | 20MG | TABLET | Resolved | 2022-09-27 | 2023-05-17 | 170272 |
| PMS-QUINAPRIL | 40MG | TABLET | Resolved | 2022-09-27 | 2023-12-23 | 170275 |
| PMS-QUINAPRIL | 5MG | TABLET | Resolved | 2022-10-28 | 2023-05-17 | 172827 |
| PMS-QUINAPRIL | 5MG | TABLET | Actual shortage | 2023-07-10 | 2025-01-07 | 198075 |
| PMS-QUINAPRIL | 10MG | TABLET | Resolved | 2023-07-10 | 2025-04-02 | 198078 |
| PMS-QUINAPRIL | 20MG | TABLET | Resolved | 2023-08-10 | 2025-04-02 | 201551 |
| PMS-QUINAPRIL | 40MG | TABLET | Resolved | 2017-03-13 | 2019-10-30 | 1927 |
| PMS-RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2018-01-26 | 2020-06-10 | 37307 |
| PMS-RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2018-04-20 | 2020-06-10 | 46738 |
| PMS-RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Avoided shortage | 2018-08-24 | 2018-10-03 | 59122 |
| PMS-RABEPRAZOLE EC | 10MG | TABLET (ENTERIC-COATED) | Actual shortage | 2021-11-15 | 2022-12-12 | 149260 |
| PMS-RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Actual shortage | 2022-08-17 | 2023-06-06 | 166914 |
| PMS-RABEPRAZOLE EC | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2018-11-29 | 2019-02-08 | 67956 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| PMSC-METFORMIN | 850MG | TABLET | To be discontinued | 2025-01-28 | 2025-01-28 | 248801 |
| SOFLAX SYRUP 4MG/ML | 20MG | SYRUP | Discontinued | 2021-04-23 | 2021-04-23 | 138006 |
| TELMISARTAN | 40MG | TABLET | Discontinued | 2017-12-15 | 2018-02-02 | 33129 |
| TELMISARTAN | 80MG | TABLET | Discontinued | 2018-07-19 | 2021-10-27 | 56080 |
| TELMISARTAN-HCTZ | 25MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25720 |
| TELMISARTAN-HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2017-10-12 | 2017-10-17 | 25724 |
| PMS-DIGOXIN | 0.250MG | TABLET | Discontinued | 2020-02-05 | 2020-02-05 | 105265 |